東方通信(600776.SH):擬減持不超83.37萬股博創科技股份
格隆匯2月17日丨東方通信(600776.SH)公佈,公司擬自博創科技股份有限公司(“博創科技”)減持計劃公告披露之日起十五個交易日後的三個月內以集中競價交易、大宗交易等合法方式減持不超過83.37萬股博創科技股份,不超過其總股本的1%。
博創科技於2003年7月8日成立,於2016年10月12日在深圳證券交易所創業板掛牌上市。截至公告日,博創科技總股本8337萬股,東方通信持有其889.65萬股,佔比10.67%。該部分股份不存在抵押、質押或者其他第三人權利,也不涉及重大爭議、訴訟或仲裁事項以及被查封、凍結等情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.